ATYR logo

ATYRaTyr Pharma, Inc

$0.4689
$0.0065
(1.37%)
Overnight
Updated: 01:23 AM EDT·Prev Close $0.4754
Reported EarningsMay 15
Mkt Cap$45.93M
Vol1.23M
News
all
press releases
aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
News Placeholder
More News
News Placeholder
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of "Hold" by Brokerages
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven research firms that are covering the stock, Marketbeat Ratings...
MarketBeat
News Placeholder
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of "Hold" by Analysts
aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recomm...
MarketBeat
News Placeholder
aTyr Pharma (NASDAQ:ATYR) Upgraded at Wall Street Zen
Wall Street Zen raised shares of aTyr Pharma from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat
News Placeholder
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting
aTyr Pharma (NASDAQ:ATYR) CEO Sanjay Shukla outlined the company's strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the...
MarketBeat
News Placeholder
Q1 Earnings Estimate for aTyr Pharma Issued By HC Wainwright
aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of aTyr Pharma in a research report issued on Friday, March 6th...
MarketBeat
News Placeholder
ATYR PHARMA INC Q4 Loss Drops
(RTTNews) - aTYR PHARMA INC (ATYR) reported Loss for fourth quarter of -$13.96 million...
Nasdaq News: Markets
News Placeholder
aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
aTyr Pharma (NASDAQ:ATYR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by...
MarketBeat
News Placeholder
aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat
News Placeholder
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Analysts
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat.com...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.